The number of removed axillary sentinel lymph nodes and its impact on the diagnostic accuracy of sentinel lymph node biopsy in breast cancer
Authors:
O. Zapletal 1; O. Coufal 1,2
; I. Selingerová 3; P. Krsička 1,2; P. Vrtělová 1,2
Authors place of work:
Masarykův onkologický ústav – Oddělení chirurgické onkologie a operačních sálů, primář: MUDr. Z. Eber
1; Masarykův onkologický ústav – Klinika komplexní onkologické péče, přednosta: Prof. MUDr. R. Vyzula, CSc.
2; Masarykova univerzita – Ústav matematiky a statistiky Přírodovědecké fakulty
ředitel: Prof. RNDr. J. Rosický, DrSc.
3
Published in the journal:
Rozhl. Chir., 2013, roč. 92, č. 1, s. 21-26.
Category:
Original articles
Práce byla podpořena Evropským fondem pro regionální rozvoj a státním rozpočtem České republiky (OP VaVpI – RECAMO, CZ.1.05/2.1.00/03.0101).
Práce byla podpořena projektem A-Math-Net Síť pro transfer znalostí v aplikované matematice (CZ.1.07/2.4.00/17.0100)
Summary
Introduction:
The number of lymph nodes removed during the sentinel lymph node biopsy in patients with breast cancer usually ranges from 1 to 3. In some cases, multiple nodes are identified and removed, which could be associated with increased risk of postoperative morbidity. The objective of the study was to assess the number of sentinel lymph nodes removed in patients treated in our hospital, to analyze factors that may influence the amount of the removed nodes, and to find if there is an upper threshold number of lymph nodes that should be removed without sacrificing the diagnostic accuracy of the sentinel lymph node biopsy.
Material and methods:
Clinical data of four hundred and forty (440) breast cancer patients who underwent sentinel lymph node biopsy in Masaryk Memorial Cancer Institute during the year 2011 were retrospectively collected and analyzed.
Results:
The number of sentinel lymph nodes ranged from 0 to 9 (average 1.7, median 1). The number of sentinel lymph nodes was significantly influenced by the age of the patient, the operating surgeon and the laterality of the surgery. In 275 cases the sentinel lymph nodes were negative, in the other cases macrometastases (n = 101), micrometastases (n = 46) or isolated tumor cells (n = 17) were found. In all the cases, but one, the staging of the axilla was determined by the status of the first three sentinel lymph nodes removed. Only in one case the first detected macrometastasis was present in the fifth node.
Conclusion:
In the vast majority of cases, the first three sentinel lymph nodes are sufficient to accurately assess the axillary status. However, with respect to the described case of first detected metastasis in the fifth node, to the present literary data and to the variability of clinical situations, we generally recommend to remove all lymph nodes meeting the criteria of the surgical definition of sentinel lymph node.
Key words:
breast cancer – sentinel lymph node biopsy – false negativity – postoperative morbidity – lymphedema.
Zdroje
1. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, Costa A, de Cicco C, Geraghty JG, Luini A, Sacchini V, Veronesi P. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;28,349(9069):1864–7.
2. Červinka V, Šťastný K, Nechvátal L, Pellant A. Nové trendy v diagnostice a léčbě karcinomu prsu na přelomu tisíciletí. Rozhl Chir 2009;2:79–83.
3. Coufal O, Fait V, Foltinová V, Vrtělová P, Gabrielová L, Chrenko V. Chirurgická léčba karcinomu prsu v MOÚ. Rozhl Chir 2007;10:540–547.
4. Gatěk J, Hnátek L, Dudešek B, Vážan P, Bakala J, Hradská K, Kotoč J, Musil T, Duben J. Biopsie sentinelové uzliny u karcinomu prsu v klinické praxi. Rozhl Chir 2008;4:180–185.
5. Sun WY, Lee KH, Lee HC, Ryu DH, Park JW, Yun HY, Song YJ. Synchronous bilateral male breast cancer: a case report. J Breast Cancer 2012;15(2):248–51.
6. Fiala L, Coufal O, Fait V, Foretová L. Karcinom prsu u mužů – naše zkušenosti. Rozhl Chir 2010;10:612–618.
7. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM, Frazier TG, Noyes RD, Robidoux A, Scarth HM, Wolmark N. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010;11 (10):927–33.
8. Chagpar AB, Carlson DJ, Laidley AL, El-Eid SE, McGlothin TQ, Noyes RD, Ley PB, Tuttle TM, McMasters KM. Factors influencing the number of sentinel lymph nodes identified in patients with breast cancer. Am J Surg 2007;194(6):860–4; discussion 864–5.
9. Lynch AL, Jackson J, Kim JA, Leeming RA. Optimal number of radioactive sentinel lymph nodes to remove for accurate axillary staging of breast cancer. Surgery 2008;144(4): 525–532.
10. Schrenk P, Rehberger W, Shamiyeh A, et al. Sentinel node biopsy for breast cancer: Does the number of sentinel nodes removed have an impact on the accuracy of finding a positive node? J Surg Oncol 2002;80:130–136.
11. McCarter MD, Yeung H, Fey J, Borgen PI, Cody HS 3rd. The breast cancer patient with multiple sentinel nodes: when to stop? J Am Coll Surg 2001;192(6):692–7.
12. Low KS, Littlejohn DR. Optimal number of sentinel nodes after intradermal injection isotope and blue dye. ANZ J Surg 2006;76(6):472–5.
13. Zakaria S, Degnim AC, Kleer CG, Diehl KA, Cimmino VM, Chang AE, Newman LA, Sabel MS. Sentinel lymph node biopsy for breast cancer: how many nodes are enough? J Surg Oncol 2007;96(7):554–9.
14. Woznick A, Franco M, Bendick P, Benitez PR. Sentinel lymph node dissection for breast cancer: how many nodes are enough and which technique is optimal? Am J Surg 2006;191(3):330–3.
15. Del Bianco P, Zavagno G, Burelli P, et al. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients results of the sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol 2008;34:508–13.
16. Veronesi U, Paganelli G, Viale G, et al. A randomised comparison of sentinel-node biopsy with routine axillary dissection in breast cancer, N Eng J Med 2003;349:546–53.
17. Swenson KK, Nissen MJ, Ceronsky C, et al. Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol 2002;9: 745–53.
18. Burak WE, Hollenbeck ST, Zervos EE, et al. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 2002;183:23–7.
19. Mansel RE, Goyal A, Newcombe RG, et al. Objective assessment of lymphedema, shoulder function and sensory deficit after sentinel node biopsy for invasive breast cancer: ALMANAC trial. Breast Cancer Res Treat 2004;88:S12.
20. Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 2006;13:491–500.
21. Guiliano AE, Haigh PI, Breannan MB, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000;18:2553–9.
22. Goldberg JI, Riedel ER, Morrow M, Van Zee KJ, Evelyn H. Morbidity of sentinel node biopsy: relationship between number of excised lymph nodes and patient perceptions of lymphedema. Ann Surg Oncol 2011;18(10):2866–72.
23. Zavagno G, Belardinelli V, Goldin E. Multiple sentinel nodes in breast cancer: how many should be removed? Breast J 2010;16:567–8.
24. Boileau J-F, Easson A, Escallon JM, et al. Sentinel nodes in breast cancer: relevance of axillary level II nodes and optimal number of nodes that need to be removed. Ann Surg Oncol 2008;15:1710–6.
25. Yi M, Meric-Bernstam F, Ross MI, et al. How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer? Cancer 2008;113:30–7.
26. Goyal A, Newcombe RG, Mansel RE. Clinical relevance of multiple sentinel nodes in patients with breast cancer. Br J Surg 2005;92:438–42.
27. Wong SL, Edwards MJ, Chao C, et al. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg 2001; 192:684–9.
28. Mac Giobuin S, Kavanagh DO, Myers E, Doherty AO, Quinn CM, Crotty T, Evoy D, McDermott EM. Removal of multiple sentinel lymph nodes in patients with breast cancer: defining the “correct” node. Acta Chir Belg 2010;110(2):185–8.
29. Kissin MW, Thompson EM, Price AB, Slavin G, Kark AE.: The inadequacy of axillary sampling in breast cancer. Lancet 1982; (8283):1210–2.
Štítky
Surgery Orthopaedics Trauma surgeryČlánok vyšiel v časopise
Perspectives in Surgery
2013 Číslo 1
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
Najčítanejšie v tomto čísle
- Hilar cholangiocarcinoma (Klatskin tumor) – current treatment options
- Complications resulting from osteosynthesis in children after supracondylar fractures of the humerus
- Primary aortoduodenal fistula (PADF)
- The number of removed axillary sentinel lymph nodes and its impact on the diagnostic accuracy of sentinel lymph node biopsy in breast cancer